Wu B, Zhu JS, Zhang Y, Shen WM, Zhang Q. Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer: One institution’s experience. World J Gastroenterol 2008; 14(19): 3064-3068 [PMID: 18494060 DOI: 10.3748/wjg.14.3064]
Corresponding Author of This Article
Dr. Qiang Zhang, MD, Department of Gastroenterology, Shanghai Sixth Hospital Affiliated to Shanghai Jiaotong University, Yishang Road 600, Shanghai 200223, China. qzsjtu@yahoo.cn
Article-Type of This Article
Rapid Communication
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Wu B, Zhu JS, Zhang Y, Shen WM, Zhang Q. Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer: One institution’s experience. World J Gastroenterol 2008; 14(19): 3064-3068 [PMID: 18494060 DOI: 10.3748/wjg.14.3064]
World J Gastroenterol. May 21, 2008; 14(19): 3064-3068 Published online May 21, 2008. doi: 10.3748/wjg.14.3064
Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer: One institution’s experience
Bin Wu, Jin-Shui Zhu, Yi Zhang, Wei-Ming Shen, Qiang Zhang
Bin Wu, Yi Zhang, Wei-Ming Shen, Department of Pharmacy, Shanghai Sixth Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200223, China
Jin-Shui Zhu, Qiang Zhang, Department of Gastroenterology, Shanghai Sixth Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200223, China
Author contributions: Wu B and Zhang Q designed and performed the research; Zhu JS contributed to the statistical advices; Zhang Y supplied the MTT assay data; Shen WM offered the MTT assay advices.
Correspondence to: Dr. Qiang Zhang, MD, Department of Gastroenterology, Shanghai Sixth Hospital Affiliated to Shanghai Jiaotong University, Yishang Road 600, Shanghai 200223, China. qzsjtu@yahoo.cn
Telephone: +86-21-64369181
Fax: +86-21-64701361
Received: February 4, 2008 Revised: March 24, 2008 Published online: May 21, 2008
Abstract
AIM: To investigate the predictive clinical value of in vitro 3-(4,5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide (MTT) assay for directing chemosensitivity in patients with gastric cancer.
METHODS: Results of a total of 353 consecutive patients with gastric cancer treated with MTT-directed chemotherapy or physician’s empirical chemotherapy from July 1997 to April 2003 were reviewed and analyzed retrospectively.
RESULTS: The overall 5-year survival rate of MTT-sensitive group (MSG) and control group (CG) was 47.5% and 45.1%, respectively. The results of subgroup analysis with Cox proportional-hazards model were favorable for the MSG-sensitive group. However, no statistically significant difference in survival rate was observed between the two groups.
CONCLUSION: Individualized chemotherapy based on in vitro MTT assay is beneficial, but needs to be confirmed by further randomized controlled trials.
